These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1355521)

  • 1. Structural changes by sulfoxidation of phenothiazine drugs.
    Dahl SG; Kollman PA; Rao SN; Singh UC
    J Comput Aided Mol Des; 1992 Jun; 6(3):207-22. PubMed ID: 1355521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorpromazine, methotrimeprazine, and metabolites. Structural changes accompanying the loss of neuroleptic potency by ring sulfoxidation.
    Dahl SG; Hjorth M; Hough E
    Mol Pharmacol; 1982 Mar; 21(2):409-14. PubMed ID: 6124878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding.
    Dahl SG; Hough E; Hals PA
    Biochem Pharmacol; 1986 Apr; 35(8):1263-9. PubMed ID: 2870716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenothiazine drug metabolites: dopamine D2 receptor, alpha 1- and alpha 2-adrenoceptor binding.
    Hals PA; Hall H; Dahl SG
    Eur J Pharmacol; 1986 Jun; 125(3):373-81. PubMed ID: 2874041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The singlet oxygen oxidation of chlorpromazine and some phenothiazine derivatives. Products and reaction mechanisms.
    Baciocchi E; Del Giacco T; Lanzalunga O; Lapi A; Raponi D
    J Org Chem; 2007 Jul; 72(15):5912-5. PubMed ID: 17595138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of levomepromazine, chlorpromazine and their sulfoxides on isolated rat atria.
    Dahl S; Refsum H
    Eur J Pharmacol; 1976 Jun; 37(2):241-8. PubMed ID: 954807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-apomorphine effects of phenothiazine drug metabolites.
    Morel E; Lloyd KG; Dahl SG
    Psychopharmacology (Berl); 1987; 92(1):68-72. PubMed ID: 2885882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenothiazine drugs: structure-activity relationships explained by a conformation that mimics dopamine.
    Feinberg AP; Snyder SH
    Proc Natl Acad Sci U S A; 1975 May; 72(5):1899-903. PubMed ID: 239403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling of antipsychotic drugs and G protein coupled receptors.
    Dahl SG; Edvardsen O; Sylte I
    Therapie; 1991; 46(6):453-9. PubMed ID: 1819151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ready biodegradability of trifluoromethylated phenothiazine drugs, structural elucidation of their aquatic transformation products, and identification of environmental risks studied by LC-MS( n ) and QSAR.
    Trautwein C; Kümmerer K
    Environ Sci Pollut Res Int; 2012 Sep; 19(8):3162-77. PubMed ID: 22678547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding affinity of levomepromazine and two of its major metabolites of central dopamine and alpha-adrenergic receptors in the rat.
    Dahl SG; Hall H
    Psychopharmacology (Berl); 1981; 74(2):101-4. PubMed ID: 6115442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic phenothiazine drugs bind to KRAS in vitro.
    Wang X; Gorfe AA; Putkey JA
    J Biomol NMR; 2021 Jul; 75(6-7):233-244. PubMed ID: 34176062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photooxidation mechanism of levomepromazine in different solvents.
    Piñero-Santiago LE; García C; Lhiaubet-Vallet V; Trzcionka J; Oyola R; Torres K; Leguillú J; Miranda MA
    Photochem Photobiol; 2013; 89(6):1479-89. PubMed ID: 23909411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on antituberculotic action of some phenothiazine derivatives in vitro.
    Molnár J; Béládi I; Földes I
    Zentralbl Bakteriol Orig A; 1977 Dec; 239(4):521-6. PubMed ID: 24964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrochemical oxidation of hydroxylated phenothiazine and imipramine derivatives.
    Neptune M; McCreery RL; Manian AA
    J Med Chem; 1979 Feb; 22(2):196-9. PubMed ID: 423199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic aspects of the oxidation of phenothiazine derivatives by methemoglobin in the presence of hydrogen peroxide.
    Kelder PP; de Mol NJ; Janssen LH
    Biochem Pharmacol; 1991 Sep; 42(8):1551-9. PubMed ID: 1930282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of presynaptic dopamine receptors by phenothiazine drug metabolites.
    Nowak JZ; Arbilla S; Dahl SG; Langer SZ
    Life Sci; 1990; 46(6):443-51. PubMed ID: 2304380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of phenothiazine derivatives to the corresponding sulphoxides on thin-layer plates.
    Kofoed J; Korczak-Fabierkiewicz C; Lucas GH
    Nature; 1966 Jul; 211(5045):147-50. PubMed ID: 5965512
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular structure and dynamics of serotonin.
    Edvardsen O; Dahl SG
    Brain Res Mol Brain Res; 1991 Jan; 9(1-2):31-7. PubMed ID: 1850076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of phenothiazines and their metabolites on prostaglandin production by rat basophilic leukemia cells in culture.
    Rigas VA; Van Vunakis H; Levine L
    Prostaglandins Med; 1981 Aug; 7(2):183-93. PubMed ID: 6116253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.